Clinical Trial Update: An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers. [Phase 1]

View source ↗

Summary

An early Phase 1 study of RT-114, a RaniPill delivering PG-102 (a GLP-1/2 dual agonist), is being conducted in healthy volunteers and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• RT-114 (RaniPill containing PG-102) (PG-102)

Snippet

Sponsor: RANI Therapeutics | Conditions: Obesity | Phase 1 | Status: RECRUITING